Association of endothelin with lung hemorrhage induced by immune complexes in rats.
The participation of endothelins (ETs) in a model of neutrophil-dependent lung injury induced by intrabronchial instillation of rabbit antibodies to ovalbumin followed by i.v. injection of the antigens (Arthus reaction) was investigated. Hemorrhagic lesions were evaluated by measuring the extravasations of hemoglobin in lung parenchyma. From 5 min to 24 h after the Arthus reaction (AR), endothelin (ir-ET) levels in bronchoalveolar lavage fluid (BALF) and in plasma were measured by radioimmunoassay. BALF levels of ir-ET were not different between control and AR animals for the first 90 min after the antigen challenge but increased from 2 to 24 h after induction of AR. ET levels in the plasma did not change from the respective controls over the same 24 h period. Increased ir-ET in BALF was not affected by pretreatment with L-NAME (30 mg/kg, i.v.). A PAF antagonist (BN52021; 5 and 10 mg/kg, i.v.) increased ET content in BALF and decreased the intensity of the AR. Thiorphan (2 mg/kg, i.v.) inhibited the AR-induced hemorrhagic lesions in lungs. An ET(A) receptor antagonist, BQ-123 (1 mg/kg, i.v.) potentiated, whereas the ET(B) antagonist, BQ-788 (1 mg/kg, i.v.) inhibited the lung hemorrhage. It is concluded that ETs are released during and play a role in the lung AR.
Teixeira
C F P
CF
Laboratory of Pharmacology, Butantan Institute, Sao Paulo, Brazil.
Jancar
S
S
Lima
W T
WT
D'Orléans-Juste
P
P
Sirois
P
P
D000818:Animals; D000936:Antigen-Antibody Complex; D001183:Arthus Reaction / Q000097:blood / Q000209:etiology / Q000276:immunology*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D004224:Diterpenes / Q000494:pharmacology; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D016232:Endothelins / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D005343:Fibrinolytic Agents / Q000494:pharmacology; D046934:Ginkgolides; D006454:Hemoglobins / Q000032:analysis; D006470:Hemorrhage / Q000209:etiology / Q000276:immunology* / Q000378:metabolism; D007783:Lactones / Q000494:pharmacology; D008171:Lung Diseases / Q000209:etiology / Q000276:immunology* / Q000378:metabolism; D008297:Male; D009504:Neutrophils / Q000276:immunology; D009842:Oligopeptides / Q000494:pharmacology; D010047:Ovalbumin; D010456:Peptides, Cyclic / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011014:Pneumonia / Q000276:immunology* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar
D000936:Antigen-Antibody Complex; D004224:Diterpenes; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D016232:Endothelins; D005343:Fibrinolytic Agents; D046934:Ginkgolides; D006454:Hemoglobins; D007783:Lactones; D009842:Oligopeptides; D010456:Peptides, Cyclic; D010880:Piperidines; C086539:BQ 788; D010047:Ovalbumin; C045856:ginkgolide B; C072247:cyclo(Trp-Asp-Pro-Val-Leu)